| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 12/06/2011 | US8071607 Mnk1 or Mnk2 inhibitors |
| 12/06/2011 | US8071606 Substituted pyrazinone amides useful for activation of glucokinase |
| 12/06/2011 | US8071605 Piperidine compounds for use in the treatment of bacterial infections |
| 12/06/2011 | US8071604 Thio-substituted arylmethanesulfinyl derivatives |
| 12/06/2011 | US8071603 Heterocyclic derivatives and their use as stearoyl-CoA desaturase inhibitors |
| 12/06/2011 | US8071602 Piperidine and piperazine derivatives |
| 12/06/2011 | US8071601 Aminoquinoline derivatives and their use as adenosine A3 ligands |
| 12/06/2011 | US8071600 Derivatives of 4-piperazin-1-yl-4-benzo[B]thiophene suitable for the treatment of CNS disorders |
| 12/06/2011 | US8071599 Methods of treatment of chronic pain using eszopiclone |
| 12/06/2011 | US8071598 3,9-diazabicyclo[3.3.1]nonane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 12/06/2011 | US8071597 Pyrazine compounds and uses as PI3K inhibitors |
| 12/06/2011 | US8071596 Endothelin receptor antagonists |
| 12/06/2011 | US8071595 1,2-disubstituted heterocyclic compounds |
| 12/06/2011 | US8071594 Substituted diketopiperazines and their use as oxytocin antagonists |
| 12/06/2011 | US8071593 2-oxo-3-benzylbenzoxazol-2-one derivatives and related compounds as Met kinase inhibitors for the treatment of tumours |
| 12/06/2011 | US8071592 Derivatives and analogs of N-ethylquinolones and N-ethylazaquinolones |
| 12/06/2011 | US8071591 7-cycloalkylaminoquinolones as GSK-3 inhibitors |
| 12/06/2011 | US8071590 9-substituted-5-carboxy-oxadiazino-quinolone derivatives, their preparation and their application as anti-bacterials |
| 12/06/2011 | US8071589 Dihydrobenzoindazoles |
| 12/06/2011 | US8071588 Dual pharmacophores—PDE4-muscarinic antagonistics |
| 12/06/2011 | US8071587 (Dihydro)imidazoiso[5,1-A]quinolines |
| 12/06/2011 | US8071586 Heterocyclyl compounds |
| 12/06/2011 | US8071585 Therapeutic agents |
| 12/06/2011 | US8071584 Indole carboxamides as IKK2 inhibitors |
| 12/06/2011 | US8071583 Pyrrolo[3,2-D] pyrimidines as DPP-IV inhibitors for the treatment of diabetes mellitus |
| 12/06/2011 | US8071582 Substituted aniline derivatives |
| 12/06/2011 | US8071580 Medium-chain length fatty alcohols as stimulators of hematopoiesis |
| 12/06/2011 | US8071579 DNA damage repair inhibitors for the treatment of cancer |
| 12/06/2011 | US8071578 Tazarotene and corticosteroid treatment for psoriasis |
| 12/06/2011 | US8071577 Multi-phase contraceptive preparation based on a natural estrogen |
| 12/06/2011 | US8071576 Fewer side effects; usable for longer period of time; lower recurrence rates after discontinuation; combination of progestogen and androgen components; kits |
| 12/06/2011 | US8071575 Methods and compounds for the targeted delivery of agents to bone for interaction therewith |
| 12/06/2011 | US8071573 Bisphosphonate compounds and methods for bone resorption diseases, cancer, bone pain, immune disorders, and infectious diseases |
| 12/06/2011 | US8071572 Hydroxypropylated starch; hyperlipidemia; visceral fat accumulation inhibitor, blood triglyceride level rise inhibitor |
| 12/06/2011 | US8071571 Orlistat compositions |
| 12/06/2011 | US8071570 Mixtures of polysaccharides derived from heparin, their preparation and pharmaceutical compositions containing them |
| 12/06/2011 | US8071569 Oxidized heparin fractions and their use in inhibiting angiogenesis |
| 12/06/2011 | US8071568 Nucleoside aryl phosphoramidates for the treatment of RNA-dependent RNA viral infection |
| 12/06/2011 | US8071567 4′-substituted nucleoside derivatives as inhibitors of HCV RNA replication |
| 12/06/2011 | US8071566 Methods of coronary imaging |
| 12/06/2011 | US8071565 Purine derivatives as a2a agonists |
| 12/06/2011 | US8071562 MiR-124 regulated genes and pathways as targets for therapeutic intervention |
| 12/06/2011 | US8071559 Compositions and methods for cancer diagnosis and treatment |
| 12/06/2011 | US8071558 Application of D-psicose to suppression of abnormal circadian increase in blood glucose level |
| 12/06/2011 | US8071557 Treatment of pulmonary hypertension with carbonic anhydrase inhibitors |
| 12/06/2011 | US8071545 Therapies and compositions for controlling the stress mechanism and for stabilizing hemostasis in an organism |
| 12/06/2011 | US8071535 Guanidinium derivatives for improved cellular transport |
| 12/06/2011 | US8071534 Material for facilitating thermal treatments of biological tissues and method of energy targeting leading to thermal treatment of biological tissues |
| 12/06/2011 | US8071531 Flavor and fragrance composition |
| 12/06/2011 | US8071316 Diagnostic method for celiac sprue |
| 12/06/2011 | US8071294 Cancer therapy sensitizer |
| 12/06/2011 | US8071133 Oral dosage forms of water insoluble drugs and methods of making the same |
| 12/06/2011 | US8071129 3′-[(2Z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazino]-2′-hydroxy-[1,1′-biphenyl]-3-carboxylic acid bis-(monoethanolamine) |
| 12/06/2011 | US8071127 Dual action, inhaled formulations providing both an immediate and sustained release profile |
| 12/06/2011 | US8071124 Methods of using expandable foam-like biomaterials |
| 12/06/2011 | US8071120 biodegradable drug delivery system containing an immunosuppressive agent and a bioerodible polymer comprising hydroxyaliphatic carboxylic acids, and polysaccharides |
| 12/06/2011 | US8071119 Controlled release implantable dispensing device and method |
| 12/06/2011 | US8071082 Drug delivery of nucleic acids, Rna, Dna; polyamideester copolymer |
| 12/06/2011 | US8071076 Oral lubricating and stain retarding compositions |
| 12/06/2011 | US8071075 Physiologically active agent, octyl dimethyl-para-aminobenzoate, volatile liquid; applying a hormone by aerosol |
| 12/06/2011 | US8071074 e.g. (6,7-(dimethoxyquinazolin-4-yl)-(3-ethynylphenyl)-amine; epidermal growth factor receptor (EGF-R) antagonist, tyrosine kinase inhibitor; hypersecretion of mucus in lungs: chronic bronchitis, acute asthma, cystic fibrosis, bronchiectasis, chronic obstructive lung disease |
| 12/06/2011 | US8071073 Compositions comprising azelastine and methods of use thereof |
| 12/06/2011 | US8070740 Processes and systems for hydrating and seeding medical implants with biological components |
| 12/06/2011 | DE202010017302U1 Retigabin-Tabletten, bevorzugt mit modifizierter Freisetzung Retigabine tablets, preferably modified release |
| 12/06/2011 | CA2651573C Pyridopyrimidinone derivatives |
| 12/06/2011 | CA2628844C Pyrazole derivatives and their medical use |
| 12/06/2011 | CA2626085C S-omeprazole strontium or hydrate thereof, method for preparing same, and pharmaceutical composition comprising same |
| 12/06/2011 | CA2626032C Camptothecin derivatives as chemoradiosensitizing agents |
| 12/06/2011 | CA2619576C Crystalline rosuvastatin intermediate |
| 12/06/2011 | CA2615019C Hiv reverse transcriptase inhibitors |
| 12/06/2011 | CA2603809C Radiotherapy enhancer |
| 12/06/2011 | CA2600570C Benzazole derivatives, compositions, and methods of use as .beta.-secretase inhibitors |
| 12/06/2011 | CA2584666C Pyrimidine derivative condensed with a non-aromatic ring |
| 12/06/2011 | CA2570807C Aminocyclohexanes as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes |
| 12/06/2011 | CA2556163C Composition comprising a benzodiazepine agonist and a benzodiazepine antagonist |
| 12/06/2011 | CA2541813C Methods for treating acute and overuse sprain and strain using hyaluronic acid |
| 12/06/2011 | CA2538748C Cobalamin conjugates for anti-tumor therapy |
| 12/06/2011 | CA2537054C 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1h-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionic acid ethyl ester-methanesulphonate and use thereof as a medicament |
| 12/06/2011 | CA2523063C 7-azaindoles and the use thereof as therapeutic agents |
| 12/06/2011 | CA2522291C Nasal pharmaceutical formulations and methods of using the same |
| 12/06/2011 | CA2519209C Method for producing 2-cyano-3-hydroxy-n(phenyl)but-2-enamides |
| 12/06/2011 | CA2517573C Substituted azetidinone compounds, formulations and uses thereof for the treatment of hypercholesterolemia |
| 12/06/2011 | CA2515146C Aerosol formulations and aerosol delivery of buspirone, buprenorphine, triazolam, cyclobenzaprine and zolpidem |
| 12/06/2011 | CA2504160C Novel alkyne compounds having an mch antagonistic effect and medicaments containing these compounds |
| 12/06/2011 | CA2501774C 2" oxo-voruscharin and derivatives thereof |
| 12/06/2011 | CA2491317C Modafinil pharmaceutical compositions |
| 12/06/2011 | CA2491243C Viral inhibitors |
| 12/06/2011 | CA2489271C Method of treating or preventing immune mediated disorders and pharmaceutical formulation for use therein |
| 12/06/2011 | CA2486759C Universal chimera bank |
| 12/06/2011 | CA2485430C Process for the preparation of a hydrate of an anthranilic acid derivative |
| 12/06/2011 | CA2485351C Cyanoguanidine prodrugs |
| 12/06/2011 | CA2483662C Heterocyclic derivatives as opioid receptor modulators |
| 12/06/2011 | CA2477748C Cosmetic compositions and methods for using same to improve the aesthetic appearance of skin |
| 12/06/2011 | CA2470837C Matrix-forming composition containing pectin |
| 12/06/2011 | CA2470791C Soft drink replacer |
| 12/06/2011 | CA2461033C Coniosulphides and their derivatives, processes for preparing them, and their use as pharmaceuticals |
| 12/06/2011 | CA2455620C Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation |
| 12/06/2011 | CA2449520C Swallow tablet comprising paracetamol |
| 12/06/2011 | CA2432027C Novel bifunctional chelating compounds containing hydroxamic acid residues |
| 12/06/2011 | CA2405031C Guaifenesin sustained release formulation and tablets |